DEK overexpression is correlated with the clinical features of breast cancer

The human DEK oncogene regulates DNA damage response signaling and repair

(2011) Gina M. Kavanaugh et al.   NUCLEIC ACIDS RESEARCH

The Oncogene DEK Promotes Leukemic Cell Survival and Is Downregulated by both Nutlin-3 and Chlorambucil in B-Chronic Lymphocytic Leukemic Cells

(2010) P. Secchiero et al.   CLINICAL CANCER RESEARCH

Control of Tumorigenesis and Chemoresistance by the DEK Oncogene

(2010) E. Riveiro-Falkenbach et al.   CLINICAL CANCER RESEARCH

DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung

(2010) T Shibata et al.   ONCOGENE

Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo

(2009) T. M. Wise-Draper et al.   CANCER RESEARCH

Melanoma Proliferation and Chemoresistance Controlled by the DEK Oncogene

(2009) M. S. Khodadoust et al.   CANCER RESEARCH

Clinicopathological significance of DEK overexpression in serous ovarian tumors

(2009) Songying Han et al.   PATHOLOGY INTERNATIONAL

DEK Proto-Oncogene Expression Interferes with the Normal Epithelial Differentiation Program

(2008) Trisha M. Wise-Draper et al.   AMERICAN JOURNAL OF PATHOLOGY

DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress

(2008) F. Kappes et al.   MOLECULAR AND CELLULAR BIOLOGY

DEK overexpression in uterine cervical cancers

(2008) Qunying Wu et al.   PATHOLOGY INTERNATIONAL